Jeevan Lifescience Profile
Key Indicators
- Authorised Capital ₹ 0.20 M
- Paid Up Capital ₹ 0.20 M
- Company Age 8 Year, 1 Month
- Last Filing with ROC 31 Mar 2019
- Open Charges ₹ 1.00 M
- Revenue Growth -13.75%
- Profit Growth -25.51%
- Ebitda 19.89%
- Net Worth 4.42%
- Total Assets 41.10%
About Jeevan Lifescience
Jeevan Lifescience Private Limited (JLPL) is a Private Limited Indian Non-Government Company incorporated in India on 05 January 2017 (Eight years and one month 8 days old ). Its registered office is in Nagpur, Maharashtra, India.
The Company is engaged in the Business Services Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2019. It's a company limited by shares with an authorized capital of Rs 0.20 M and a paid-up capital of Rs 0.20 M.
The company currently has active open charges totaling ₹1.00 M.
Sachin Pawankar and Atul Sisode serve as directors at the Company.
Company Details
-
Location
Nagpur, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
-
Website
-
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U74999MH2017PTC289327
-
Company No.
289327
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
05 Jan 2017
-
Date of AGM
30 Sep 2019
-
Date of Balance Sheet
31 Mar 2019
-
Listing Status
Unlisted
-
ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Jeevan Lifescience?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sachin Pawankar
|
Director | 05-Jan-2017 | Current |
|
Atul Sisode
|
Director | 05-Jan-2017 | Current |
Financial Performance of Jeevan Lifescience.
Jeevan Lifescience Private Limited, for the financial year ended 2019, experienced significant reduction in revenue, with a 13.75% decrease. The company also saw a substantial fall in profitability, with a 25.51% decrease in profit. The company's net worth moved up by a moderate rise of 4.42%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Jeevan Lifescience?
Unlock access to Jeevan Lifescience's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Sssarr Cura Private LimitedAtul Sisode is a mutual person
Charges (Loans)
₹1.00 M
₹0
Charges Breakdown by Lending Institutions
- Others : 0.10 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 16 Sep 2019 | Others | ₹1.00 M | Open |
How Many Employees Work at Jeevan Lifescience?
Unlock and access historical data on people associated with Jeevan Lifescience, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Jeevan Lifescience, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Jeevan Lifescience's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
